Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)

Zhang, Bo ; Shi, Chunlei ; Gao, Zhiqiang ; Zhong, Hua ; Xiong, Liwen ; Gu, Aiqin ; Wang, Weimin ; Chu, Tianqing ; Zhang, Wei ; Wang, Huimin ; Zhang, Xueyan ; Zhong, Runbo ; Han, Baohui

BMC cancer, 2022-03, Vol.22 (1), p.294-294, Article 294 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível